secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2026-07-22T21:07:10+00:00
Accession:  0001356576-26-000031
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus to report Q2 2026 results on August 4, 2026
----------------------------------------------------

- Earnings release after market close on Tuesday, August 4, 2026.
- Conference call at 4:30 p.m. ET that day; webcast replay available for 60 days.
- No preliminary financial results or guidance provided in this announcement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657626000031/0001356576-26-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657626000031/supn-20260722.htm
  HTML page:      https://secwatch.observer/filing/0001356576-26-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer